Health Condition 1: H309- Unspecified chorioretinal inflammation
Conditions
Interventions
Intervention1: SUPRACHOROIDAL INJECTION TRIAMCINOLONE IN PATIENTS OF NON-INFECTIOUS UVEITIS: SINGLE SUPRACHOROIDAL INJECTION TRIAMCINOLONE 0.1 ml GIVEN UNDER ASEPTIC PRECAUTIONS AND POST INJECTION FOL
Sponsors
GSVM MEDICAL COLLEGE
Eligibility
Inclusion criteria
Inclusion criteria: 1) Newly diagnosed patients of non-infectious anterior uveitis. (2) Newly diagnosed patients of non-infectious intermediate uveitis. (3) Newly diagnosed patients of non-infectious posterior uveitis
Exclusion criteria
Exclusion criteria: (1) Patients not willing to participate or ready for follow up. (2) Patients with uncontrolled blood sugar. (3) Patients with any ocular disease other than uveitis. (4) Patients contraindicated for suprachoroidal injection eg. thinned sclera, scleritis, staphylococcus. (5) Patients of hypersensitivity for Triamcinolone. (6) Patients diagnosed of any other posterior segment pathologies.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1) BCVA 2) Slit lamp examination 3) Intra ocular pressure Timepoint: 3 days after injection | — |
Secondary
| Measure | Time frame |
|---|---|
| BCVA Slit lamp examination Intraocular pressure Indirect ophthalmoscopic assessment of fundusTimepoint: 15days after injection;BCVA Slit lamp examination Intraocular pressure Indirect ophthalmoscopic assessment of fundus USG B Scan assessment of posterior segment OCT to assess resolution of Macular oedemaTimepoint: 1month after injection | — |
Countries
India
Contacts
Public ContactRITU
GANESH SHANKAR VIDYARTHI MEDICAL COLLEGE
Outcome results
None listed